A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Trial details
- Registry ID
- NCT06678659
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic CancerNCT06678659 | RXRX | Phase 1, Phase 2 | Recruiting | 2029-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |